Location: Home
  • search
  • go
  • Relate News
  • 4/15/2021Hugel Expands China Presence with New Subsidiary in Shanghai
  • 4/15/2021NMPA Issues the Principles of Classification and Definition of Recombi...
  • 4/15/2021CDE Publicizes the List of Reference Formulations for GQCE Studies (42...
  • 4/15/2021CDE Issues the Guidance Principles on Real World Data Used to Produce ...
  • 4/15/2021Latest Update on the Upcoming 5th Round of VBP
  • 4/15/2021China Issues the 2021 Work Highlights of the Healthy China Initiative
  • 4/15/2021Numerous Local Champions and MNCs Among the 19 Pharma Cos Fined by the...
  • 4/15/2021How China Passed Up a Vaccine Opportunity and Fell Behind
  • 4/14/2021Chinese MOF Fines 19 Pharma Companies for Inflating Drug Prices
  • 4/14/2021Sanofi Unveils New R&D Facility in Suzhou
  • 4/14/2021AZ's Tagrisso Approved in China as Adjuvant Treatment for Early EGFRm ...
  • 4/14/2021StoneWise Raises $100M to Promote Use of AI in Drug Development
  • 4/14/2021Denovo's Licenses DB102 (Enzastaurin) for Rare Genetic Pediatric Onset...
  • 4/14/2021CAMS and PUMC Review Chinese Cancer Trends from 1990 to 2017
  • 4/14/2021CMJ: Changing Profiles of Cancer Burden Worldwide and in China
  • 4/14/2021Simcere's Marketing Application for First-to-copy Ibrutinib Accepted b...
  • 4/14/2021BioDuro-Sundia Initiates GMP Clinical Batch Manufacturing at New China...
  • 4/14/2021Eli Lilly Licenses Greater China Rights of Alpha-synuclein Targeted Th...
  • 4/14/2021SAMR Fines Yangtze River Pharma CNY 764M for Violations of Anti-Monop...
  • 4/13/2021Abcam and MEDx Extend Precision Medicine Strategic Partnership
  • 4/13/2021Pharma MNCs Step Up Alliances with Local Players in Chinese Market
  • 4/13/2021China Approves New COVID-19 Vaccine for Clinical Trials
  • 4/13/2021CDE Solicits Comments on the Technical Guidelines for Clinical Trial o...
  • 4/13/2021NMPA Revises Package Inserts of Tramadol Hydrochloride Suppository and...
  • 4/13/2021CNIPA Invalidates Pfizer's Chinese Patent of Sutent (Sunitinib)
  • 4/12/2021Review of R&D Spending of Listed Chinese Biopharma Firms 2018-2020
  • 4/12/2021NMPA Accepts NDA for Ocumension's OT-401 (YUTIQ) on Real World Data
  • 4/12/2021Sorrento Therapeutics To Buy ACEA Therapeutics For $38M in Stock
  • 4/12/2021NMPA Outlines Process and Prospects of ICH in China at Latest Symposiu...
  • 4/12/2021CDE Solicits Comments on Proposed Technical Guidelines for BE Study of...
  • Page:191/775 Total number of articles:23243: [First][<<] [189] [190] [191] [192] [193] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group